Empagliflozin vs Zolpidem
Empagliflozin vs Zolpidem: Overview
This comparison examines the pharmacological differences between Empagliflozin and Zolpidem.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Zolpidem: Selective GABA-A receptor alpha-1 subunit agonist.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Zolpidem β 2.5 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Zolpidem β C19H21N3O.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Zolpidem β 307.3950 g/mol.
Type: Empagliflozin β Small molecule; Zolpidem β Small molecule.